About Careers MedBlog Contact us

Novel Vaccine Shows Promise against Chikungunya Virus

by Iswarya on December 26, 2018 at 10:28 AM
Font : A-A+

Novel Vaccine Shows Promise against Chikungunya Virus

Novel vaccine which is developed based on a modified measles virus shows a promise against the chikungunya virus, reports a new clinical trial study. The findings of the study are published in the journal The Lancet.

The Phase II trial, led by the University of Vienna in Austria, showed that just two injections are enough to provide immunity, regardless of whether these are given at an interval of one or six months.


The vaccine is injected into the muscle and triggers the production of antibodies in the lymphatic system. If the person is infected with the chikungunya virus, these antibodies are ready to neutralize the virus so that the disease does not take hold.

The results "are very promising in terms of immunogenicity, safety, and tolerability of the vaccine," said Ursula Wiedermann-Schmidt, Professor from the varsity.

The vaccine is a live vaccine based on the measles virus vaccinal strain, which has been genetically modified to express the surface proteins of chikungunya.

Neutralising antibodies are formed after a single vaccination.

Also, it increases or boosts the protective substances or antibodies against measles.

The Phase II trials were conducted over 263 volunteers.

Chikungunya fever is an emerging viral disease, and a substantial threat to public health and the virus is spreading throughout the world particularly in India, Indonesia, Sri Lanka, and Thailand.

Currently, there is no specific treatment capable of halting the chikungunya virus and the associated high fever with severe muscle, limb and joint pain, which can even prove fatal under certain circumstances.

Source: IANS


Recommended Reading

Latest Tropical Disease News

Oral Cholera Vaccine Launched in India by Pharma Giants
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Evolving Threat of Dengue Virus in India
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
 Watch Out for Acute Kidney Disease as a Complication of Malaria
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
India's Malaria Vaccine Gets the Green Light for First Time in Ghana
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
 Deadly Dengue Virus Hijacks Mosquito Saliva to Spread Sickness
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Novel Vaccine Shows Promise against Chikungunya Virus Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests